Arman Qamar: We are Routinely Evaluating VTE PRS in the Clinic in Many of Our Patients With Unprovoked VTE
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn:
“We are routinely evaluating VTE PRS in the clinic in many of our patients with unprovoked VTE. We discuss the evolving science in our recent review.”
Quoting RPTH Journal post:
“Recent studies demonstrate that polygenic risk score (PRS) significantly improves VTE risk prediction beyond traditional clinical factors. Recent findings indicate that PRS could inform thromboprophylaxis decisions for high-risk patients.”
Title: Role of polygenic risk scores in venous thromboembolism: current state and future directions
Authors: Aman Goyal, Sonia Hurjkaliani, Kevin Michael Alexander, Jianfeng Xu, Manan Pareek, Arman Qamar
Read full article here.
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 07:35Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
-
Sep 5, 2026, 05:48Punit Mathur: From Leg Pain to Life-Threatening Pulmonary Embolism
-
Sep 5, 2026, 05:44Patrick Stonich: Identifying Missed Signs of Postoperative Pulmonary Embolism in Medical Record Reviews
-
Sep 5, 2026, 05:38Tom Van den Hoek: Warburg Effect Mimicking Refractory Shock in Cancer-Associated PE
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology
-
Sep 5, 2026, 04:51Samuel Nwokolo: The Bone Marrow Factory – Anatomy of Blood Production
-
Sep 5, 2026, 04:37Maryam Alaa Alsaid: Diagnostic Puzzle of Sickle Beta Thalassemia
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress